Asia
Jinhe Biotechnology Directors Approve Two US Projects for $31.9 Million
Jinhe Biotechnology (SHE:002688) directors approved two projects in the U.S. worth $31.9 million, according to a Tuesday filing with the Shenzhen Stock Exchange.The company invested $5.9 million for the upgrade of its veterinary chemical drug facility in Omaha, Nebraska, and $26 million for a veterinary vaccine factory in Newport, Minnesota.
SHE:002688
